Genentech, Seattle Genetics Collaborate In Antibody Program
By Kim Coghill
Tuesday, April 23, 2002
Genentech Inc. will strengthen its long-standing relationship with Seattle Genetics Inc. by paying up to $50 million for access to technology to build its cancer program.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.